| 5 | 1/1 | 返回列表 |
| 查看: 7884 | 回復(fù): 28 | ||
| 【懸賞金幣】回答本帖問題,作者枯荷聽雨1988將贈送您 29 個金幣 | ||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | ||
枯荷聽雨1988木蟲 (小有名氣)
|
[求助]
SCI修回后Accept Pending Receipt of Missing Items是什么意思? 已有2人參與
|
|
|
求助:文章修回后狀態(tài)變?yōu)锳ccept Pending Receipt of Missing Items。我想知道我們?nèi)笔Я耸裁?該如何回?fù)?非常感謝! 系統(tǒng)意見如下: We are pleased to inform you that at this point, the scientific content requires no further revision and we are prepared to officially accept your article. We have been able to use your submitted paper for the review process and now that the paper is going to go into production, there are a couple of small things that need to be done to ensure smooth processing. Throughout the text we found the following statement "(Refer Supporting information)" that needs some clarification. Please carefully check your manuscript and resubmit updated version. Please now take the following steps: 1. Log into the Elsevier Editorial System for International Journal of Pharmaceutics as an Author: https://ees.elsevier.com/ Your username is: ###### If you need to retrieve password details, please go to: https://ees$$$$$$$ 2. Locate IJP-D-17-00874R1 in your 'Submissions Needing Revision' folder. 3. Check the "File Inventory" to ensure that all of the items listed below are included: *Manuscript Source Files: We cannot accommodate PDF manuscript files for production purposes. Refer to the Guide for Authors for additional information: https://www.%%%% *Figure Source Files: Please make sure that artwork files are in an acceptable format (TIFF, EPS or embedded within single Word file) and with the correct resolution: https://www.### 4. Submit your revised paper by clicking 'Submit Revision' and completing the submission steps. Note: Be sure to include a separate document uploaded as "Response to Reviewers" that carefully addresses, point-by-point, the issues raised in this letter (i.e. "My paper now includes manuscript and figure source files. " .Data in Brief (optional) We invite you to convert your supplementary data (or a part of it) into a Data in Brief article. Data in Brief articles are descriptions of the data and associated metadata which are normally buried in supplementary material. They are actively reviewed, curated, formatted, indexed, given a DOI and freely available to all upon publication. Data in Brief should be uploaded with your revised manuscript directly to International Journal of Pharmaceutics. If your International Journal of Pharmaceutics research article is accepted, your Data in Brief article will automatically be transferred over to our new, fully Open Access journal, Data in Brief, where it will be editorially reviewed and published as a separate data article upon acceptance. The Open Access fee for Data in Brief is $500. Please just fill in the template found here: https://www.elsevier.com/inca/pu ... her%20journals.docx Then, place all Data in Brief files (whichever supplementary files you would like to include as well as your completed Data in Brief template) into a .zip file and upload this as a Data in Brief item alongside your International Journal of Pharmaceutics revised manuscript. Note that only this Data in Brief item will be transferred over to Data in Brief, so ensure all of your relevant Data in Brief documents are zipped into a single file. Also, make sure you change references to supplementary material in your International Journal of Pharmaceutics manuscript to reference the Data in Brief article where appropriate. Questions? Please contact the Data in Brief publisher, Paige Shaklee at dib@elsevier.com Example Data in Brief can be found here: https://www.sciencedirect.com/science/journal/23523409 |
木蟲之王 (文學(xué)泰斗)
peterflyer
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料求調(diào)劑 +9 | 呢呢妮妮 2026-04-01 | 11/550 |
|
|---|---|---|---|---|
|
[考研] 材料調(diào)劑 +12 | 一樣YWY 2026-04-01 | 12/600 |
|
|
[考研] 11408 321分求調(diào)劑 +3 | huchun12138 2026-03-30 | 4/200 |
|
|
[考研] 安全工程 285 求調(diào)劑 +3 | Xinyu56 2026-04-01 | 4/200 |
|
|
[考研] 342求調(diào)劑 +12 | Mary Keen 2026-03-28 | 13/650 |
|
|
[考研] 285求調(diào)劑 +7 | AZMK 2026-03-30 | 13/650 |
|
|
[考研] 材料專業(yè)調(diào)劑 +5 | 啦啦啦哭 2026-03-31 | 6/300 |
|
|
[考研] 材料0856 英一數(shù)二 323 求調(diào)劑 +9 | 袁sy 2026-04-01 | 9/450 |
|
|
[考研] 085410人工智能 初試316分 求調(diào)劑 +3 | 殘星拂曙 2026-03-31 | 3/150 |
|
|
[考研] 調(diào)劑申請 +8 | 張張張張zy 2026-03-31 | 9/450 |
|
|
[考研] 335求調(diào)劑 +3 | 321* 2026-03-31 | 4/200 |
|
|
[考研] 070300化學(xué)專業(yè)279調(diào)劑 +10 | 哈哈哈^_^ 2026-03-31 | 10/500 |
|
|
[考研] 本2一志愿C9-333分,材料科學(xué)與工程,求調(diào)劑 +9 | 升升不降 2026-03-31 | 9/450 |
|
|
[考研] 085601英二數(shù)二求調(diào)劑 總分325 +4 | 余航航 2026-03-31 | 4/200 |
|
|
[考研] 0856 335分 +9 | cccchenso 2026-03-29 | 9/450 |
|
|
[考研] 一志愿中海洋材料357 +4 | 麥恩莉. 2026-03-30 | 4/200 |
|
|
[有機(jī)交流]
10+3
|
kaobao456 2026-03-29 | 4/200 |
|
|
[考研] 0703化學(xué)321分求調(diào)劑 +10 | 三dd. 2026-03-30 | 11/550 |
|
|
[考研] 284求調(diào)劑 +14 | junqihahaha 2026-03-26 | 15/750 |
|
|
[考研] 332求92調(diào)劑 +8 | 蕉蕉123 2026-03-28 | 8/400 |
|